DEPLOYDatabase

Company

Zimmer Biomet

surgical robotzimmerbiomet.com

Zimmer Biomet, American orthopedic medical device company developing robotic surgery platforms ( Rosa) for joint replacement surgery.

Track Zimmer Biomet
HQ
Warsaw, IN
Status
public (NYSE: ZBH)

The verified answer

As of Sep 2026, DEPLOY verifies Zimmer Biomet: 1 model, 2 deployments across 2 regions, 15 active incidents. 3 sources back the record.

Regulatory status2 FDA 510(k) clearances1 FDA recall

Zimmer Biomet holds 2 FDA 510(k) clearances and has 1 FDA recall on record, per the DEPLOY registry.

See all 3 filings
PublicNYSE: ZBH

CategorySurgical robots

Models

1

Deployments

2

Deploy Watch

Track Zimmer Biomet on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track Zimmer Biomet

Key facts

Product

ROSA robotic surgical assistant (Knee/Hip/Brain/Shoulder); cross-domain ortho + neuro.

Boundary

AI-augmented surgeon-controlled assistance, NOT autonomous (autonomy is the separate Monogram line).

Stock listing

NYSE: ZBH

ROSA origin

ROSA originated at Medtech SA

Acquisition year

Medtech SA acquired in 2016

ROSA platform

ROSA Knee (with OptimiZe, FDA-cleared Nov 2025), ROSA Brain, ROSA Spine

ROSA Knee price

$700,000-$1,500,000

Data & sources

Press releases

2

Web sources

1

3 sources backing this record.View all →

Models (1)

View all models →

Current platform

ROSA

ROSA, the Robotic Surgical Assistant, is Zimmer Biomet's surgeon-controlled robotic-arm platform, recorded in the surgical form factor as the mid-size, multi-procedure archetype of the orthopedic sub-cohort and the one that crosses surgical sub-domains, spanning orthopedics and neurosurgery from a single robotic-arm and navigation architecture. The arm is coupled to optical navigation and two- and three-dimensional planning software and positions or guides instruments, but it moves only on surgeon command and does not cut or place autonomously, so ROSA is AI-augmented surgeon-controlled assistance rather than autonomous surgery and is in scope as a surgical robot. Made by Zimmer Biomet Holdings, listed on the New York Stock Exchange as ZBH and headquartered in Warsaw, Indiana, ROSA originated at the French company Medtech SA, founded in 2002 in Montpellier by Bertin Nahum, which built ROSA Brain and ROSA Spine; Zimmer Biomet acquired Medtech SA in 2016 at fifty euros per share and extended the ROSA arm into orthopedics. The current Zimmer Biomet variants are ROSA Knee for total knee arthroplasty, cleared January 25, 2019 and enhanced as ROSA Knee with OptimiZe cleared November 14, 2025, ROSA Hip for direct anterior total hip arthroplasty cleared August 18, 2021, ROSA ONE Brain for cranial neurosurgery including biopsy, stereo-electro-encephalography, deep brain stimulation, and ventricular and transnasal endoscopy cleared February 11, 2019, and ROSA Shoulder for shoulder arthroplasty cleared in February 2024. ROSA ONE Spine, cleared in 2019, left Zimmer Biomet in the March 2022 ZimVie spinoff and is no longer a Zimmer Biomet product. A registry nuance worth recording is that autonomy enters Zimmer Biomet's portfolio separately through its Monogram Technologies acquisition, completed October 7, 2025, which brings a CT-based semi-autonomous total-knee robot and a fully-autonomous version in development; this is kept distinct from ROSA, whose surgeon-controlled status is unchanged. Installed-base figures circulating in aggregators conflict and none is asserted here.

surgicalView model →

Partnerships

Every company Zimmer Biomet has built with, alongside the ones only announced in a press release.

3 total1 operating2 just announced

Most-frequent partners

  1. 1NVIDIA1× joint1108 total
  2. 2PeritasAI1× joint6 total
  3. 3PeritasAI1× joint
  4. 4THINK Surgical1× joint4 total

Most recent

  1. Zimmer Biomet x PeritasAI x NVIDIA2026-06-15
    with PeritasAIjust announced
  2. PeritasAI x NVIDIA x Zimmer Biomet Surgical AI2026-03-16
    with PeritasAIoperating

Zimmer Biomet on the deployment map

View the global map

2 verified deployments across 2 regions, newest verified Jan 2020. Explore where Zimmer Biomet's robots are operating, by place and type.

Free to use on your site, with a link back to DEPLOY.

View the full Zimmer Biomet deployment record →

Free to use on your site, with a link back to DEPLOY.

Relationships

TTHINK SurgicalCo-developerPPeritasAITechnology partnerNNVIDIATechnology partnerPPublic MarketInvestorZZimmer BiometCustomer

Current leadership (2)

ArrivalsGreg Roche from Distalmotion

DeparturesGreg Roche to Distalmotion

Board (1)

Former / Previously (1)

  • Greg Roche Global President, Robotics & Technologysecondary-verified

Media (1)

Company-anchored media. Official assets the company has published at the company level, distinct from model-anchored media that lives on individual product pages.

Safety record

12 recalls and 3 incidents on record (1 catastrophic, 2 critical, 12 serious). Most recent: Jun 2026.

catastrophic
1
critical
2
serious
12
recall
12
malfunction
2
injury
1

Most recent: Jun 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Zimmer Biomet (15)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operator customers (1)

Recent coverage

Zimmer Biomet in third-party press

Zimmer Biomet: $1 Billion Buyback Target Expands As Next-Generation ROSA Shoulder Begins First Procedures

Aug 12, 2026

Zimmer Biomet Announces Second Quarter 2026 Financial Results

Aug 5, 2026

Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation

Jul 8, 2026

Peers

41 peers across 1 segment. Every Zimmer Biomet competitor derived from shared form-factor and application-domain edges.

surgical robot(41)

28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%